Zentalis Pharmaceuticals, Inc. (ZNTL) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ZNTL…

Zentalis Pharmaceuticals, Inc. (ZNTL) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Zentalis Pharmaceuticals, Inc.

ZNTL · CIK 1725160

4 · Oct 1, 2026 · Chief Medical Officer Bruns Ingmar was granted 9,727 shares at $2.18/share ($21,205)

4

Chief Medical Officer Bruns Ingmar was granted 9,727 shares at $2.18/share ($21,205)

Filed: Oct 1, 2026
Period: Sep 30, 2026
Accession: 0001628280-26-064317
Filer: Zentalis Pharmaceuticals, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1790889591.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1790889591.xml
Open SEC.gov